Insider Selling: Arteris (NASDAQ:AIP) COO Sells 17,937 Shares of Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) COO Laurent Moll sold 17,937 shares of the firm’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $17.92, for a total value of $321,431.04. Following the sale, the chief operating officer directly owned 275,159 shares in the company, valued at approximately $4,930,849.28. This represents a 6.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Arteris Price Performance

AIP stock traded up $1.01 during mid-day trading on Tuesday, reaching $19.19. The company had a trading volume of 1,112,895 shares, compared to its average volume of 590,407. The stock has a 50 day simple moving average of $13.75 and a two-hundred day simple moving average of $10.77. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.30. The company has a market capitalization of $838.22 million, a price-to-earnings ratio of -23.12 and a beta of 1.48.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.25%.The firm had revenue of $17.41 million for the quarter, compared to analyst estimates of $17.00 million. On average, equities analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on AIP. Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. TD Cowen raised their price objective on shares of Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Cowen restated a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a research report on Tuesday, October 28th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $17.50.

View Our Latest Research Report on AIP

Institutional Investors Weigh In On Arteris

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new position in Arteris in the 2nd quarter worth approximately $32,000. BNP Paribas Financial Markets boosted its stake in shares of Arteris by 75.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock worth $61,000 after purchasing an additional 2,595 shares during the period. Savant Capital LLC bought a new position in shares of Arteris during the second quarter valued at approximately $97,000. Kapitalo Investimentos Ltda purchased a new stake in Arteris in the second quarter worth $104,000. Finally, Strs Ohio bought a new stake in shares of Arteris during the first quarter valued at approximately $104,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.